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proteasome to generate the transcriptionally competent
NF-B isoforms p52 and p50, respectively. The degrada-
tion of IB proteins that permits NF-B molecules to
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Building 10, Room 290 move into the nucleus is also carried out by the protea-
some but only after prior phosphorylation of IB by theSouth San Francisco, California 94080
2 Ontario Cancer Institute IB kinase complex (IKK). The IKK is composed of three
subunits: two, IKK and IKK, are bona fide kinases,620 University Avenue
Toronto, Ontario M5G 2C1 while the third, IKK (NEMO), has no catalytic activity
but plays a critical regulatory role. In vitro, both IKKCanada
and IKK phosphorylate two specific serine residues
within the N terminus of IB; however, in vivo, IKK
is the predominant IB kinase. Phosphorylated IB isThe involvement of the transcription factor NF-B in
a plethora of cellular activities has made it one of the recognized by -TrCP, a component of the SCF (skp-1/
Cul/F box) ubiquitin ligase complex that mediates poly-most studied proteins. The emerging understanding
of new roles for NF-B and complexities of the regula- ubiquitination of IB and its subsequent proteasomal
degradation (reviewed in Karin and Ben-Neriah, 2000).tion of its function was the focus of a recent Juan
March workshop held recently in Madrid, Spain. In contrast, IKK mediates the phosphorylation-depen-
dent processing of p100, resulting in the generation of
p52. While the upstream kinase responsible for activa-The NF-B family of transcription factors are involved
tion of IKK remains unclear, it is evident that NIK (NF-mainly in stress-induced, immune, and inflammatory re-
B-inducing kinase) activates IKK by phosphorylatingsponses. In addition, these molecules play important
it within its activation loop, at least in vitro (see Figure 1).roles during the development of certain hemopoietic
cells, keratinocytes, and lymphoid organ structures.
More recently, NF-B family members have been impli- Regulation by Degradation
cated in neoplastic progression and the formation of Conventional wisdom holds that a central point of NF-
neuronal synapses. These important and diverse func- B regulation is the translocation of activated NF-B
tions make NF-B one of the most studied transcrip- from the cytoplasm to the nucleus. Cytoplasmic reten-
tional factors in biology. Members of this family are tion of the inactive IB/NF-B complex is thought to
formed by dimeric combinations of subunits and are be due to the masking of the dual nuclear localization
activated by a number of receptor-mediated signaling signals (NLS) located on NF-B by IB. Gourisankar
pathways. Once activated, they stimulate the transcrip- Ghosh (San Diego) discussed the need to modify this
tion of specific sets of target genes mediating a plethora simplistic model in light of the crystal structure of IB
of diverse functions. To examine these various activa- complexed to NF-B p50. Study of this structure re-
tion pathways and outcomes, the Juan March Founda- vealed that only one NLS is masked by IB while the
tion organized a meeting held in Madrid on October 7–9, other is still free. The presence of a free NLS gives
2002. credence to recent observations that IB/NF-B com-
plexes are dynamic in nature and can shuttle between
Primer the cytoplasm and nucleus. Also presented was the
There are five members of the NF-B family of transcrip- structure of IB bound to the NF-B p65 homodimer.
tion factors: Rel (c-Rel), Rel A (p65), Rel B, NF-B1 (p105/ In this case, one NLS was masked by IB, but the other
p50), and NF-B2 (p100/p52). Together, these proteins was only very loosely associated with the inhibitor. The
regulate the expression of genes encoding cytokines, complex should, therefore, be competent to translocate
chemokines, adhesion molecules, and antimicrobial to the nucleus. However, other work has shown that the
peptides, thereby orchestrating both innate and adap- IB/p65 complex is primarily cytosolic because IB
tive immune responses (reviewed in Ghosh and Karin, engages a GTP binding accessory protein, B-Ras,
2002). NF-B/Rel proteins exist as homo- or hetero- which binds a specific insert domain in IB (Fenwick
dimers and possess a conserved N-terminal Rel homol- et al., 2000). When bound to B-Ras, IB cannot be
ogy domain that mediates dimerization as well as DNA phosphorylated by IKK. Therefore, a prerequisite for NF-
binding. All NF-B/Rel proteins interact with a group of B signaling is the dissociation of IB from B-Ras.
inhibitory proteins termed the IB family. The IB and Elucidation of the mechanism underlying this dissocia-
IB proteins are the prototypes of the seven-member tion and the exact role of B-Ras await additional bio-
IB family. Interestingly, the p100 and p105 precursor chemical studies and the generation of B-Ras null
forms of the Rel proteins NF-B1 and NF-B2 share mice.
homology with IB. IB-related proteins possess multi- As stated above, phosphorylated IB is recognized
ple ankyrin repeats that interact with the Rel homology by the -TrCP component of the SCF ubiquitination
domain present in NF-B molecules. These ankyrin re- complex. Yinon Ben-Neriah (Jerusalem) used RNAi
peats are removed from p100 and p105 by the cellular knockdown studies in HeLa cells to conclusively show
that -TrCP is the critical substrate binding component
of the SCF ubiquitination complex. Following TNF stim-3Correspondence: dixit@gene.com
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Figure 1. Pathways Leading to the Activation
of NF-B
This outline is meant to provide an elementary
conceptual framework for components in-
volved in receptor-mediated NF-B activa-
tion discussed at the meeting. See text for
details.
ulation, massive amounts of phosphorylated IB accu- tion in mature and late transitional B cells in spleen;
early transitional B cells that had recently migrated intomulate in the presence of a dominant-negative (F box-
deleted) -TrCP. Yet, in the absence of the E3 receptor spleen from bone marrow were essentially unaffected
(Claudio et al. 2002). This phenotype resembles that ofsubunit, fully stabilized IB is markedly dephosphory-
lated, indicating the role of -TrCP in preserving IB BlyS/BAFF null mice, which also display a paucity of
mature and late transitional B cells but possess earlyphosphorylation prior to ubiquitylation. An enigma re-
mains, however, due to the localization of these binding transitional B cells. NF-B2-deficient but not NF-B1-
deficient B cells exhibited a partial block at the samepartners. -TrCP resides in the nucleus while its sub-
strate IB is cytosolic. Here again one must invoke the stage of maturation. Furthermore, bone marrow cultures
from NF-B1 null mice responded to the antiapoptoticnuclear shuttling of the IB/NF-B complex as a means
of delivering phospho-IB to nuclear -TrCP. The reten- effects of recombinant BlyS/BAFF, but NF-B2 null bone
marrow cultures did not. These results are consistenttion of -TrCP in the nucleus is mediated by hnRNP-U, a
pseudosubstrate that binds to the WD-40 domain within with a vital role for NF-B2 in B cell survival. In addition,
bone marrow cultures from Aly mice, which possess a-TrCP (Davis et al., 2002). hnRNP-U is not ubiquitinated
but does occupy the IB binding site until phospho- defective NIK gene, responded poorly to BlyS/BAFF, in
keeping with NIK being part of the survival pathway.IB, the true and higher-affinity substrate, is available.
Knockdown of hnRNP-U by RNAi leads to constitutive Finally, the ability of BAFF to induce NF-B2 processing
leading to p52 generation was compromised in AWySnJdegradation of IB, presumably because -TrCP is no
longer held in check and is free to act on IB. mice, which have a mutated form of BAFF-R/BR-3.
Taken together, these results are consistent with a sce-
nario in which BAFF-R/BR-3 engagement leads to BNonclassical NF-B Signaling Pathways
The classical signaling pathway leading to the activation cell survival via a pathway involving components of the
nonclassical NF-B activation pathway. Vishva Dixitof NF-B is mediated by IKK and results in the phos-
phorylation of IB. This pathway lies downstream of all (South San Francisco) discussed the potential therapeu-
tic applications of disrupting BAFF:BR3 signaling in au-known proinflammatory stimuli including TNF, IL-1, LPS,
and double-stranded RNA. In contrast, the nonclassical toimmune diseases such as lupus. Treatment of NZB/
WF1 mice, which develop fatal lupus nephritis with re-NF-B activation pathway involves IKK and leads to
the phosphorylation of p100 and its subsequent pro- combinant BR3-Fc, a soluble decoy receptor for BAFF,
resulted in remarkable attenuation of the disease pro-cessing to p52. IKK is itself activated by the upstream
kinase NIK. The NIK/IKK/NF-B2 pathway is activated cess characterized by a sharp decline in mortality, devel-
opment of autoantibodies, and renal damage. Structuralby engagement of the lymphotoxin  receptor (LTR) in
stromal nonlymphoid cells and likely drives the produc- characterization of the ligand binding interface of BR3
led to the synthesis of a 12-residue structured -hairpintion of B-lymphocyte chemoattractant, a cytokine re-
quired for proper lymphoid organ development, as dis- peptide that blocked BAFF-mediated NFB2/p52 induc-
tion in primary B cells (Kayagaki et al. 2002).cussed by Ulrich Siebenlist (Bethesda). Experiments
presented from this laboratory also showed that the Interestingly, BlyS/BAFF-induced p52 generation was
inhibited by cycloheximide, suggesting that this processNIK/IKK/NF-B2 signaling pathway is activated in B
cells by engagement of the receptor BAFF-R/BR-3 by may depend on protein synthesis. Claus Scheidereit
(Berlin) showed that, in a mechanistically similar way,the B cell survival factor BlyS/BAFF. This conclusion
stems from the characterization of NF-B1 and NF-B2 lymphotoxin  and LPS, but not TNF or IL-1, stimu-
lated p100 processing and the accumulation of p52 DNAdouble null bone marrow stem cells transplanted into
RAG-deficient recipient mice. While there was no overt binding complexes. As for BlyS/BAFF, LPS- and
LT-induced p100 processing was delayed when com-defect in T cell development, there was a marked reduc-
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pared to p50/p65 complexes and depended on protein activation, but not PMA-induced ERK activation, is
blocked in NF-B1 null macrophages. The defect ap-de novo synthesis. LT- or LPS-induced p100 pro-
cessing was accompanied by p100 ubiquitination and pears to be attributed to the upstream kinase Tpl2 that
activates the MEK/ERK signaling pathway in responserequired ongoing p100 translation, suggesting that pro-
cessing was induced at the level of the ribosome (Mord- to LPS but not PMA. Gioacchino Natoli (Bellinzona) dis-
cussed how sustained p38 MAP kinase activation (whichmuller et al., 2002). In this regard, results presented
by Shao-Cong Sun (Hershey) may be pertinent. The C influences chromatin structure) regulates the recruit-
ment of NF-B to target promoters. The ramificationsterminus of NF-B2 was subjected to a yeast two-hybrid
analysis and found to bind a component of the protea- of this result are that, even with prerequisite posttransla-
tional modification, NF-B may not initiate transcriptionsome lid (S9) (Fong et al., 2002). It is possible that this
or a similar molecule is the protein synthesis-dependent if coordinate activation of the appropriate kinase cas-
cades has not resulted in chromatin remodeling and“p100-processing factor.” The same laboratory also re-
ported on the mechanisms by which Tax, the trans- promoter accessibility. These results are in keeping with
the observation that NF-B must be activated with sus-forming protein encoded by the adult T cell leukemia
virus (HTLV-1), induces NF-B2 processing. Apparently, tained kinetics to be recruited to, and activate, genes
requiring remodeling to become accessible to NF-Btax functions to recruit IKK to p100, thereby promoting
p100 phosphorylation and subsequent processing (Xiao proteins (Hoffmann et al., 2002).
Another kinase family that modulates NF-B tran-et al., 2001).
scriptional activity is that containing the atypical PKC
isoforms  and . Dominant-negative forms of either ofRole and Regulation of NF-B
these kinases inhibit NF-B activation. A role for PKCTranscriptional Activity
in NF-B signaling was confirmed by the characteriza-It is becoming evident that activation of NF-B as as-
tion of PKC null mice by Jorge Moscat (Madrid). Thesesessed by IB degradation, NF-B nuclear transloca-
mutant animals exhibit significant retardation in the de-tion, or binding to DNA is not synonymous with tran-
velopment of secondary lymphoid organs and impairedscriptional activation. Rather, activation also involves
B cell proliferative responses as well as inhibited induc-posttranslational modification of NF-B/Rel proteins,
tion of the NF-B target genes IB, IL-6, and Bcl-XLparticularly p65. Indeed, Claus Scheidereit had pre-
(Leitges et al., 2001; Martin et al., 2002). Furthermore,viously shown p65 to be phosphorylated following cellu-
an inducible interaction between PKC and p65 waslar stimulation. His laboratory has extended this ob-
detected, as was PKC-mediated phosphorylation ofservation to demonstrate that not only is NF-B
p65. It is likely that the atypical PKCs influence NF-Btranscriptional activation subject to posttranslational
transcriptional activity by posttranslationally modifyingregulation, but LPS-induced increase in AP-1 DNA bind-
p65 and other Rel proteins.ing activity also requires NF-B activation. The implica-
tions of this surprising result are clear: there must be
regulated crosstalk between major signaling pathways, Role of NF-B in Cancer and Inflammation
It is well known that exposure of cells to chemotherapeu-and the activity of one can be a prerequisite for the
activity of the other. tic agents results in the induction of both proapoptotic
factors such as p53 and the activation of antiapoptoticIn keeping with this theme of the importance of post-
translational modification for transcriptional activation, pathways like that mediated by NF-B. The balance
between these two opposing forces determines the finalGuy Haegeman (Gent) showed that, while induction of
IL-6 by TNF depends on an NF-B response element cell fate. That these life and death forces are more inti-
mately related was revealed by the work of Inder Vermawithin the IL-6 promoter, it also requires concurrent acti-
vation of ERK and p38 MAP kinases. Pharmacological (La Jolla). In IKK/ double knockout cells, apoptosis
induced by chemotherapeutic agents is especially pro-inhibition of these kinases leads to an attenuation of
TNF-mediated IL-6 induction despite IB degradation, found, presumably due to the absence of NF-B-depen-
dent antiapoptotic mechanisms. Notably, in this setting,NF-B nuclear localization, and unaltered DNA binding
capacity. This observation raises the possibility that the the induction of p53 is pronounced as if the absence of
NF-B stabilizes p53 and promotes its accumulationphosphorylation of NF-B by MAP kinases is required
for transcriptional activation. While neither p50 or p65 (Tergaonkar et al., 2002). Reintroduction of IKK or IKK
into the doubly null cells showed that IKK was respon-are direct substrates for MAP kinases, p65 can be phos-
phorylated by MSK1, a nuclear kinase located down- sible for the destabilization of p53. While the mechanis-
tic details remain to be determined, it is clear that, in thestream of ERK and p38. MSK1 phosphorylates NF-B
p65 at Ser 276, an event required for transcriptional absence of NF-B, there is a corresponding reduction in
mdm2, the protein that normally functions to eliminateactivity. It thus represents, together with the phosphory-
lation of particular nucleosome components (e.g., his- p53 by ubiquitination. The ability to sensitize cells to
chemotherapeutic agents by inhibiting NF-B has madetone H3), an essential step leading to selective transcrip-
tional activation of specific NF-B-dependent genes. It the IKKs attractive enzymatic targets for the develop-
ment of cancer therapeutics.is likely that this scenario will be played out repeatedly,
with different protein kinases modulating the transcrip- With the advent of orally active IKK-specific inhibitors
as reported by Frank Mercurio (San Diego), it is becom-tional activity of NF-B by regulated phosphorylation of
p65 and other Rel proteins, as well as of chromatin ing increasingly important to address the potential toxic-
ity of these drugs; that is, toxicity associated with thecomponents. The laboratory of Shao-Cong Sun has
been seeking to understand why LPS-mediated ERK loss of NF-B function. Michael Karin (San Diego) de-
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scribed experiments in which IKK null mice could be paracaspase/MALT1, also appear to function in the
rescued from fatal TNF-induced liver apoptosis if they same pathway of antigen receptor-induced NF-B acti-
were crossed into a TNFR1/ background. However, vation. Taken together, these results put on solid ground
the mice still succumbed to opportunistic infections the hypothesis that NF-B activation has a role in neo-
within 2 to 3 weeks of birth, despite being kept in sterile plasia. The most likely scenario is that NF-B mediates
conditions. While one might suspect that these deaths survival and antiapoptotic signals that promote tumori-
were due to the important role NF-B plays in the activa- genesis.
tion of lymphoid and myeloid immune system cells, spe-
cific deletion of IKK in these tissues only extended NF-B in Innate Immunity
the survival of the mice to 6 months of age. Another The role of NF-B in innate immunity was expanded
possibility is that NF-B induction may initially occur in upon by Rudi Beyaert (Gent) who discussed the phe-
nonimmune system cells such as epithelial cells. Epithe- nomenon of LPS tolerance. Exposure to a sublethal dose
lial cells are often the first line of defense against invad- of LPS protects a mouse from subsequent challenge
ing pathogens and can participate in inflammatory reac- with a dose that is normally lethal to a naive animal.
tions by synthesizing proinflammatory cytokines like Beyaert and colleagues characterized alternatively
TNF. The animal system used to explore the impor- spliced forms of MyD88, the proximal adaptor molecule
tance of NF-B activation to the innate immune re- involved in IL-1R- and TLR-induced activation of NF-B.
sponse and inflammation was an ischemia/reperfusion MyD88 contains a C-terminal TIR (Toll/IL-IR) homology
injury model in which clamping of the superior mesen- domain and a N-terminal death domain (DD). The TIR
teric artery results in a period of intense intestinal isch- domain mediates binding to the receptor, whereas the
emia. Reperfusion following clamp release causes the DD recruits IL-1R-associated kinase-1 (IRAK1). In col-
generation of reactive oxygen species (ROS) within the laboration with the group of Jurg Tschopp (Lausanne),
ischemic region and an acute inflammatory response Beyaert and colleagues now found that an intermediate
resembling septic shock. Copious amounts of TNF are domain of MyD88 mediates the recruitment of IRAK4.
released into the systemic circulation, leading to lung This positioning leads to the phosphorylation of IRAK1
damage characterized by neutrophil infiltration and by IRAK4, triggering the dissociation of IRAK1 from the
edema similar to adult respiratory distress syndrome. receptor and subsequent activation of the IKK signalo-
In TNFR1 null mice, this type of ischemia/reperfusion some. A splice variant of MyD88, termed MyD88S, is
procedure does not result in lung damage, confirming expressed in the spleen and is highly LPS inducible
that TNF is involved in the pulmonary pathology. The (Janssens et al., 2002). Overexpression studies revealed
question arises: what tissue in the injured gut releases that MyD88S could function as a dominant-negative in-
the TNF? Conditional ablation of the IKK gene specifi- hibitor of IL-1- and LPS-induced NF-B activation.
cally in epithelial cells (enterocytes) significantly damp- MyD88S lacks the intermediate domain so that the adap-
ened IKK activity in the gut mucosa and attenuated TNF tor still binds IL-1R and IRAK1 but is unable to recruit
release such that no lung injury was observed. The gut IRAK4. IRAK phosphorylation does not occur and NF-
mucosa, however, were severely injured, probably be-
B activation is abrogated. In the case of a mouse
cause the antiapoptotic activity of NF-B was no longer
treated with a sublethal dose of LPS, dominant-negative
present to protect the gut lining from ROS-mediated
MyD88S may be induced, which could potentially make
damage. Inhibiting IKK (albeit by genetic means) in this
cells refractory to further challenge by LPS.instance turned out to be a double-edged sword in that
In Drosophila, innate immune mechanisms are thethe lung was saved but at the expense of the gut.
primary defense against pathogens (reviewed in Sil-Michael Karin and colleagues also characterized the
verman and Maniatis, 2001). Injection of bacteria or fungirole of NF-B activation in a colitis-associated model
into a fly results in a massive synthesis of antimicrobialfor colorectal cancer. Preliminary results suggest a sig-
peptides by the fat body (an organ roughly equivalentnificant reduction in tumor incidence, which can be at-
to the mammalian liver). Jules Hoffmann (Strasbourg)tributed to the above-mentioned ablation of IKK in en-
described two NF-B-like proteins responsible for theterocytes. However, the mechanism underlying this
transcriptional activation of these antimicrobial pep-observation is yet to be determined. While these intri-
tides: Dif and Relish. Dif is normally cytoplasmic byguing findings hint at a role for NF-B in solid tumor
virtue of its binding to Cactus, an IB-like inhibitor. Nu-progression, the part NF-B plays in lymphoma develop-
clear translocation of Dif occurs upon activation of thement is now becoming clear. Tak Wah Mak (Toronto)
Toll transmembrane receptor by a proteolytically pro-presented data to support the function of these tran-
cessed cytokine termed Spaetzle. This processing ofscription factors in the development of both Hodgkin’s
Spaetzle is predominantly induced by the presence ofdisease and MALT lymphomas. In the former case, NF-
fungi and gram-positive bacteria via extracellular pro-B signaling (possibly triggered by CD30 engagement
teolytic cascades initiated upon interaction of microbialand TNF signaling) may confer a survival advantage on
patterns with circulating proteins (e.g., peptidoglycanthe Reed-Sternberg tumor cells. This work also impli-
recognition proteins). In contrast, as shown by Dan Hult-cated the cytokine IL-13 as an important autocrine
mark (Umea), gram-negative bacteria mostly lead to thegrowth factor driving the division of Reed-Sternberg
eventual activation of Relish by inducing the endopro-cells. In the case of MALT lymphomas, chromosomal
teolytic cleavage that removes the C-terminal ankyrintranslocations involving the BCL-10 gene result in
repeats of Relish. The DNA binding N-terminal Rel-strong, constitutive activation of NF-B signaling linked
homology domain of Relish can then translocate to theto antigen receptor stimulation. Two other proteins as-
sociated with MALT lymphomas, BIMP/CARD11 and nucleus. A DD-containing adaptor called imd initiates
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Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiqui-the proteolytic cleavage cascade that activates Relish.
tination: the control of NF-B activity. Annu. Rev. Immunol. 18,Again, the parallels with the mammalian innate immune
621–663.system are thought provoking, with a Toll-like receptor,
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J.F.,DD-containing adaptor, and regulated proteolysis being
Camacho, F., Diaz-Meco, M.T., Rennert, P.D., and Moscat, J. (2001).
key conserved features in both species. Targeted disruption of the zetaPKC results in the impairment of the
NF-kappaB pathway. Mol. Cell 8, 771–780.
Martin, P., Duran, A., Minguet, S., Gaspar, M.L., Diaz-Meco, M.T.,For the Future
Rennert, P., Leitges, M., and Moscat, J. (2002). Role of zeta PKC inThis very interesting meeting ended with the participants
B-cell signaling and function. EMBO J. 21, 4049–4057.agreeing on a set of future goals and common aspira-
Mordmuller, B., Krappmann, D., Esen, M., Wegener, E., and Schei-tions. While it is clear that many different pathways con-
dereit, C. (2002). Lymphotoxin- and lipopolysaccharide-induced NF-verge onto the IKK complex, much work remains to be
B-p52 generation by co-translational mechanism. EMBO Rep., in
done to understand how IKK complex action translates press.
biochemically into the assembly of various NF-B homo- Silverman, N., and Maniatis, T. (2001). NF-B signaling pathways in
and heterodimers. Several complementary approaches mammalian and insect innate immunity. Genes Dev. 15, 2321–2342.
were proposed to attack this problem. Bruce Beutler Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., and Verma, I. (2002).
(La Jolla) has proposed a forward genetics screening p53 stabilization is decreased upon NFkappaB activation: a role for
NfkappaB in acquisition of resistance to chemotherapy. Cancer Cellprogram in whole animals to identify genes involved in
1, 493–503.innate immunity and NF-B signaling, while Dan Hult-
Xiao, G., Cvijic, M.E., Fong, A., Harhaj, E.W., Uhlik, M.T., Waterfield,mark presented convincing data to support the notion
M., and Sun, S.C. (2001). Retroviral oncoprotein Tax induces pro-that study of lower organisms like Drosophila have much
cessing of NF-kappaB2/p100 in T cells: evidence for the involvementto offer. In addition, we must recognize that the identity
of IKKalpha. EMBO J. 20, 6805–6815.
of downstream genes activated by NF-B will be directly
influenced not only by the specific combinations of ho-
mo- or heterodimeric subunits but also by the cellular
context in which they operate. Along this line, the delin-
eation of the biophysical properties of the various NF-
B homo- and heterodimers and the determination of
conformational differences among them may throw light
onto how biological specificities are achieved. Finally,
defining the heterogeneity of NF-B target genes will
be a prerequisite for contemplating clinical intervention
in diseases (such as inflammation and cancer) resulting
from deregulated NF-B activation. Knowledge gained
from these combined approaches may serve as the ba-
sis for the identification of mechanistically based thera-
peutics and drug targets.
References
Claudio, E., Brown, K., Park, S., Wang, H., and Siebenlist, U. (2002).
BAFF-induced NEMO-independent processing of NF-kappa B2 in
maturing B cells. Nat. Immunol. 10, 958–965.
Davis, M., Hatzubai, A., Andersen, J.S., Ben-Shushan, E., Fisher,
G.Z., Yaron, A., Bauskin, A., Mercurio, F., Mann, M., and Ben-Neriah,
Y. (2002). Pseudosubstrate regulation of the SCF (beta-TrCP) ubiqui-
tin ligase by hnRNP-U. Genes Dev. 16, 439–451.
Fenwick, C., Na, S.Y., Voll, R.E., Zhong, H., Im, S.Y., Lee, J.W.,
and Ghosh, S. (2000). A subclass of Ras proteins that regulate the
degradation of IkappaB. Science 287, 869–873.
Fong, A., Zhang, M., Neely, J., and Sun, S.C. (2002). S9, a 19S
proteasome subunit interacting with ubiquitinated NF-kappa B2/
p100. J. Biol. Chem. 277, 40697–40702.
Hoffmann, A., Levchenko, A., Scott, M.L., and Baltimore, D. (2002).
The Ikappa B-NF-kappa B signaling module: temporal control and
selective gene activation. Science 298, 1241–1245.
Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-B puzzle.
Cell 109, S81–S96.
Janssens, S., Burns, K., Tschopp, J., and Beyaert, R. (2002). Regula-
tion of interleukin-1- and lipopolysaccharide-induced NF-kappaB
activation by alternative splicing of MyD88. Curr. Biol. 12, 467–471.
Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French,
D.M., Grewal, I.S., Cochran, A.G., Gordon, N.C., Yin, J., et al. (2002).
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand
through a discrete surface loop and promotes processing of NF-
kappaB2. Immunity 17, 515.
